Aarti Pharmalabs Limited (AARTIPHARM.BO)
INR 577.0
(2.11%)
INR 577.0
(2.11%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 6.42 Billion INR | 6.78% |
| 2022 | 6.02 Billion INR | 26.62% |
| 2021 | 4.75 Billion INR | 0.0% |
| 2020 | - INR | 0.0% |
| 2019 | - INR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 7.19 Billion INR | 0.0% |
| 2024 Q1 | - INR | -100.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 FY | 6.42 Billion INR | 6.78% |
| 2023 Q2 | 6.02 Billion INR | 0.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q4 | 6.42 Billion INR | 0.0% |
| 2022 FY | 6.02 Billion INR | 26.62% |
| 2022 Q4 | 6.02 Billion INR | 1.82% |
| 2022 Q3 | 5.91 Billion INR | 0.0% |
| 2021 Q1 | - INR | 0.0% |
| 2021 FY | 4.75 Billion INR | 0.0% |
| 2021 Q4 | 4.75 Billion INR | -0.0% |
| 2021 Q3 | 4.75 Billion INR | 0.0% |
| 2021 Q2 | - INR | 0.0% |
| 2020 FY | - INR | 0.0% |
| 2019 FY | - INR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Ajanta Pharma Limited | 8.28 Billion INR | 22.394% |
| Amrutanjan Health Care Limited | 289.04 Million INR | -2124.067% |
| Sigachi Industries Limited | 707.2 Million INR | -809.012% |
| Bal Pharma Limited | 878.11 Million INR | -632.092% |
| Ind-Swift Laboratories Limited | 104.57 Million INR | -6047.241% |
| Medico Remedies Limited | 163.37 Million INR | -3834.946% |
| Lasa Supergenerics Limited | 190.43 Million INR | -3275.763% |
| Venus Remedies Limited | 1.21 Billion INR | -428.277% |
| Sun Pharma Advanced Research Company Limited | - INR | -Infinity% |
| Alpa Laboratories Limited | 136.65 Million INR | -4604.324% |
| Nectar Lifesciences Limited | 7.09 Billion INR | 9.348% |
| Shilpa Medicare Limited | 3.44 Billion INR | -86.375% |
| Aarti Drugs Limited | 4.85 Billion INR | -32.306% |
| Lupin Limited | 49.53 Billion INR | 87.023% |
| Aurobindo Pharma Limited | 98.08 Billion INR | 93.446% |
| Zydus Lifesciences Limited | 34.41 Billion INR | 81.323% |
| Windlas Biotech Limited | 621.89 Million INR | -933.72% |
| Suven Life Sciences Limited | 7.08 Million INR | -90635.356% |
| Eris Lifesciences Limited | 1.89 Billion INR | -240.08% |
| Valiant Laboratories Limited | 100.15 Million INR | -6318.715% |
| J. B. Chemicals & Pharmaceuticals Limited | 5.02 Billion INR | -27.93% |
| Solara Active Pharma Sciences Limited | 3.59 Billion INR | -78.721% |
| Ipca Laboratories Limited | 24.71 Billion INR | 73.987% |
| Bliss GVS Pharma Limited | 1.18 Billion INR | -442.739% |
| Achyut Healthcare Limited | 568 Thousand INR | -1131695.775% |
| Sun Pharmaceutical Industries Limited | 98.68 Billion INR | 93.486% |
| Bajaj HealthCare Limited | 1.44 Billion INR | -346.312% |
| RPG Life Sciences Limited | 1.01 Billion INR | -536.495% |
| Mankind Pharma Limited | 15.53 Billion INR | 58.618% |
| Laurus Labs Limited | 18.45 Billion INR | 65.164% |
| Piramal Pharma Limited | 21.75 Billion INR | 70.455% |
| Syncom Formulations (India) Limited | 210.81 Million INR | -2949.404% |
| Torrent Pharmaceuticals Limited | 22.79 Billion INR | 71.792% |
| Alembic Pharmaceuticals Limited | 16.43 Billion INR | 60.886% |
| Glenmark Pharmaceuticals Limited | 25.13 Billion INR | 74.419% |
| Unichem Laboratories Limited | 7.04 Billion INR | 8.772% |
| Sequent Scientific Limited | 3.46 Billion INR | -85.673% |
| Novartis India Limited | 448.6 Million INR | -1333.036% |
| Wanbury Limited | 360.23 Million INR | -1684.572% |
| Suven Pharmaceuticals Limited | 2.31 Billion INR | -178.059% |
| Wockhardt Limited | 6.4 Billion INR | -0.447% |
| Themis Medicare Limited | 705.74 Million INR | -810.898% |
| Jagsonpal Pharmaceuticals Limited | 149.97 Million INR | -4186.591% |
| Jubilant Pharmova Limited | 12.89 Billion INR | 50.15% |
| Glenmark Life Sciences Limited | 6.66 Billion INR | 3.56% |
| Dr. Reddy's Laboratories Limited | 63.55 Billion INR | 89.885% |
| Divi's Laboratories Limited | 31.84 Billion INR | 79.81% |
| NATCO Pharma Limited | 7 Billion INR | 8.228% |
| Gufic Biosciences Limited | 2 Billion INR | -220.657% |
| IOL Chemicals and Pharmaceuticals Limited | 4.24 Billion INR | -51.318% |
| Ind-Swift Limited | 640.91 Million INR | -903.035% |
| Procter & Gamble Health Limited | 1.09 Billion INR | -489.185% |
| FDC Limited | 3.88 Billion INR | -65.307% |
| Krebs Biochemicals & Industries Limited | 97.96 Million INR | -6462.207% |
| Granules India Limited | 13 Billion INR | 50.57% |
| Medicamen Biotech Limited | 593.75 Million INR | -982.708% |
| Alkem Laboratories Limited | 26.61 Billion INR | 75.843% |
| AstraZeneca Pharma India Limited | 2.27 Billion INR | -182.102% |
| Biofil Chemicals and Pharmaceuticals Limited | 25.49 Million INR | -25113.162% |
| Brooks Laboratories Limited | 96.1 Million INR | -6588.933% |
| Megasoft Limited | - INR | -Infinity% |
| ZIM Laboratories Limited | 812.62 Million INR | -691.087% |
| Strides Pharma Science Limited | 11.26 Billion INR | 42.92% |
| Neuland Laboratories Limited | 3.5 Billion INR | -83.453% |
| Morepen Laboratories Limited | 2.48 Billion INR | -158.598% |
| Hikal Limited | 3.03 Billion INR | -111.662% |
| Indoco Remedies Limited | 3.53 Billion INR | -82.082% |
| Kilitch Drugs (India) Limited | 39.88 Million INR | -16019.86% |
| Mangalam Drugs & Organics Limited | 1.23 Billion INR | -419.946% |
| Hester Biosciences Limited | 755.81 Million INR | -750.558% |